A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors

Clinical trial NCT05234606 · WITHDRAWN

Trial details

NCT number: NCT05234606
Sponsor: Silverback Therapeutics
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Urothelial Carcinoma Triple Negative Breast Cancer Non-small Cell Lung Cancer Squamous Cell Carcinoma of Head and Neck Hormone Receptor-positive/HER2-negative Breast Cancer

Start date: 2022-03-01
Primary completion: 2022-03-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.